References
- Link SL, Rampon G, Osmon S, et al. Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series. Clin Toxicol. 2021:1–6. DOI:https://doi.org/10.1080/15563650.2021.1996591.
- Wong A, Sivilotti ML, Dargan PI, et al. External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clin Toxicol. 2015;53(8):807–814.
- Sivilotti ML, Green TJ, Langmann C, et al. Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose. Clin Toxicol. 2010;48(8):793–799.
- Radke JB, Algren DA, Chenoweth JA, et al. Transaminase and creatine kinase ratios for differentiating delayed acetaminophen overdose from rhabdomyolysis. West J Emerg Med. 2018;19(4):731. Jul
- Maskell KF, Powell SW, Willis D, et al. Patterns of transaminase elevation in rhabdomyolysis versus acetaminophen toxicity. Am J Emerg Med. 2021;44:362–365.
- Rasamison R, Besson H, Berleur MP, et al. Analysis of fomepizole safety based on a 16-year post-marketing experience in France. Clin Toxicol. 2020;58(7):742–747.